-
Something wrong with this record ?
Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients
J. Stuk, J. Vanasek, K. Odrazka, M. Dolezel, I. Kolarova, A. Hlavka, M. Vitkova, Z. Sinkorova
Language English Country Cyprus
Document type Journal Article
PubMed
34268957
Knihovny.cz E-resources
- MeSH
- Acute Disease MeSH
- Chronic Disease MeSH
- Gastrointestinal Tract physiopathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Prostatic Neoplasms complications MeSH
- Radiotherapy, Image-Guided methods MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Urogenital System physiopathology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
PURPOSE: This paper compares individual radiation therapy techniques used for prostate cancer and their benefits in clinical practice. METHODS: We retrospectively analyzed 921 patients with localized prostate tumors treated between 1997 and 2012. We divided the patients into four groups according to the selected treatment technique (conformal radiation therapy [3DCRT], intensity-modulated radiation therapy [IMRT], image-guided radiation therapy [IGRT], and volumetric-modulated arc therapy [VMAT]) and evaluated the incidence of acute and chronic gastrointestinal (GI) and genitourinary (GU) toxicity. RESULTS: The incidence of grade 2 or greater acute GU and GI toxicity was significantly higher among techniques other than IGRT (p˂0.001). We found the same results in the case of grade 3 or greater acute GU toxicity (p˂0.001). Grade 3 or higher acute GI toxicity occurred only in one patient treated by 3DCRT. Cumulative late GI toxicity of grade 2 or higher and grade 3 or higher was recorded over 3 years significantly more frequently among non-IGRT techniques as compared to IGRT (p˂0.001). As regards GU toxicity, we found significantly higher incidence only for grade 2 or higher (p˂0.001), not for grade 3 or higher. No occurrence of grade 4 toxicity was recorded. The greatest incidence of patients without acute and chronic GI/GU toxicity was recorded in connection with VMAT. CONCLUSION: IGRT demonstrated a pronounced reduction in acute and chronic GU and GI toxicity as compared to non-IGRT techniques in the treatment of localized prostate cancer.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004402
- 003
- CZ-PrNML
- 005
- 20220127145302.0
- 007
- ta
- 008
- 220113s2021 cy f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)34268957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a cy
- 100 1_
- $a Stuk, Jan $u Department of Clinical and Radiation Oncology, Oncology Centre, Multiscan and Pardubice Hospital, Pardubice, Czech Republic
- 245 10
- $a Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients / $c J. Stuk, J. Vanasek, K. Odrazka, M. Dolezel, I. Kolarova, A. Hlavka, M. Vitkova, Z. Sinkorova
- 520 9_
- $a PURPOSE: This paper compares individual radiation therapy techniques used for prostate cancer and their benefits in clinical practice. METHODS: We retrospectively analyzed 921 patients with localized prostate tumors treated between 1997 and 2012. We divided the patients into four groups according to the selected treatment technique (conformal radiation therapy [3DCRT], intensity-modulated radiation therapy [IMRT], image-guided radiation therapy [IGRT], and volumetric-modulated arc therapy [VMAT]) and evaluated the incidence of acute and chronic gastrointestinal (GI) and genitourinary (GU) toxicity. RESULTS: The incidence of grade 2 or greater acute GU and GI toxicity was significantly higher among techniques other than IGRT (p˂0.001). We found the same results in the case of grade 3 or greater acute GU toxicity (p˂0.001). Grade 3 or higher acute GI toxicity occurred only in one patient treated by 3DCRT. Cumulative late GI toxicity of grade 2 or higher and grade 3 or higher was recorded over 3 years significantly more frequently among non-IGRT techniques as compared to IGRT (p˂0.001). As regards GU toxicity, we found significantly higher incidence only for grade 2 or higher (p˂0.001), not for grade 3 or higher. No occurrence of grade 4 toxicity was recorded. The greatest incidence of patients without acute and chronic GI/GU toxicity was recorded in connection with VMAT. CONCLUSION: IGRT demonstrated a pronounced reduction in acute and chronic GU and GI toxicity as compared to non-IGRT techniques in the treatment of localized prostate cancer.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a gastrointestinální trakt $x patofyziologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory prostaty $x komplikace $7 D011471
- 650 _2
- $a radioterapie řízená obrazem $x metody $7 D061089
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a urogenitální systém $x patofyziologie $7 D014566
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vanasek, Jaroslav
- 700 1_
- $a Odrazka, Karel
- 700 1_
- $a Dolezel, Martin
- 700 1_
- $a Kolarova, Iveta
- 700 1_
- $a Hlavka, Ales
- 700 1_
- $a Vitkova, Martina
- 700 1_
- $a Sinkorova, Zuzana
- 773 0_
- $w MED00005361 $t Journal of Balkan Union of Oncology $x 2241-6293 $g Roč. 26, č. 3 (2021), s. 940-948
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34268957 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145258 $b ABA008
- 999 __
- $a ok $b bmc $g 1751767 $s 1155551
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 3 $d 940-948 $e - $i 2241-6293 $m Journal of Balkan Union of Oncology $n J BUON $x MED00005361
- LZP __
- $a Pubmed-20220113